Home / David L. Joffe, BSPharm, CDE, FACA (page 20)

David L. Joffe, BSPharm, CDE, FACA

David L. Joffe, BSPharm, CDE, FACA
(Editor-in-Chief Diabetes In Control) A graduate of University of Kentucky College of Pharmacy, he has practiced in the Tampa Bay area since 1986, has been providing diabetes and cardiovascular care in Tampa Bay since 1995, and spent 2 years as an Eckerd Patient Care Pharmacist managing over 100 diabetes patients. Dave currently sees patients in over 30 primary care and endocrinologists offices.

Dec. 23, 2017

Happy holidays from the entire staff here at Diabetes in Control. This week we add another SGLT-2 inhibitor to our armada of diabetes medications. This new drug, Ertugliflozin, (see news flash) is coming to the market as a stand alone and in combination with both a DPP-4 inhibitor and Metformin. …

Read More »

Dec. 19, 2017

Over the past 10 years the number of car brands has decreased. GM once had 8 nameplates and now they are down to 4. They used to have a brand for every age bracket, with Buick being the name badge for their old people’s car (I can say that because …

Read More »

Dec. 16, 2017

My good friend David Kliff always seems to hit the nail on the head when it comes to evaluating diabetes companies and the battles for insurance coverage and pricing. He often discusses the idea that insulin is a commodity, and formulary choices are not based on advertised prices, but on …

Read More »

Dec 12, 2017

Today I watched a news feature on the use of robots as supervisors of humans doing jobs. Last week another show listed jobs that robots would do, and unfortunately pharmacists was one of those jobs. When you add in driverless cars and drone delivery it is not hard to see …

Read More »

Dec. 9, 2017

For many years cardiovascular disease has been the number one cause of death among diabetes patients. So getting a CV benefit from diabetes drugs is a definite plus. Over the past few weeks Dr. Aaron Vinik has been sharing his views on the values of Cycloset for both diabetes and …

Read More »

Dec 7, 2017

When a parent finds out that their child has type 1 diabetes all they can think of is getting their glucose under control. After they get used to the changes for the child and the family, they start to look for ways to either minimize the damage diabetes causes, or …

Read More »

Dec. 5, 2017

This week, we want to help you simplify your selection of injectables for patients. While most patients often think that an injection is always insulin, we know that is not true. We also have GLP-1 analogs, as well as combinations of these products, so in our Homerun Slides, we make …

Read More »

Dec. 2, 2017

It has been over 20 years since I started my journey in diabetes care. When I started, the education field was dominated by nurses and dietitians, and most of them were female. Oftentimes, when I was asked to serve on advisory boards for pharma companies, I would find I was …

Read More »

Nov. 28, 2017

Dr Aaron Vinik has worked with us for many years and I am continually fascinated by his forward thinking and the respect he garners from the top opinion leaders in diabetes. Over the past 10 years, there have been researchers who seem to have a left-field idea that may just …

Read More »

Nov. 25, 2017

A few years ago I served as president of the Tampa Bay chapter of JDRF. At the same time one of my good Pharmacist-CDE friends was president of the local ADA chapter, and we would always tease each other as to who was raising the most money for our respective …

Read More »